Table I.
Parameter | Total | HHLA2 expression
|
P-value | |
---|---|---|---|---|
Low | High | |||
Patients (n) | 89 | 44 | 45 | |
Sex | 0.244 | |||
Male | 37 | 21 | 16 | |
Female | 52 | 23 | 29 | |
Age (years) | 0.899 | |||
<62 | 49 | 24 | 25 | |
≥62 | 40 | 20 | 20 | |
Differentiation | 0.219 | |||
Poorly or moderately | 21 | 13 | 8 | |
Well | 48 | 22 | 26 | |
Nevin stage | 0.014 | |||
I-III | 37 | 24 | 13 | |
IV-V | 52 | 20 | 32 | |
American Joint Committee on Cancer stage | 0.007 | |||
I-II | 36 | 24 | 12 | |
III-IV | 53 | 20 | 33 | |
Tumor invasion | ||||
T1-T2 | 44 | 27 | 17 | 0.026 |
T3-T4 | 45 | 17 | 28 | |
Regional node metastasis | ||||
Absent | 46 | 29 | 17 | 0.018 |
Present | 31 | 11 | 20 | |
Distant metastasis | ||||
Absent | 61 | 34 | 27 | 0.079 |
Present | 28 | 10 | 18 |
HHLA2, human endogenous retrovirus-H long terminal repeat-associating protein 2.